ATR Stock - AptarGroup, Inc.
Unlock GoAI Insights for ATR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.58B | $3.49B | $3.32B | $3.23B | $2.93B |
| Gross Profit | $1.36B | $1.26B | $1.16B | $1.16B | $1.09B |
| Gross Margin | 37.8% | 36.2% | 35.0% | 35.8% | 37.1% |
| Operating Income | $496.50M | $404.02M | $379.27M | $347.35M | $339.50M |
| Net Income | $374.54M | $284.49M | $239.29M | $244.10M | $214.04M |
| Net Margin | 10.5% | 8.2% | 7.2% | 7.6% | 7.3% |
| EPS | $5.65 | $4.34 | $3.66 | $3.72 | $3.32 |
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Visit WebsiteEarnings History & Surprises
ATREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | $1.25 | — | — | — |
Q4 2025 | Oct 30, 2025 | $1.57 | $1.62 | +3.2% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $1.58 | $1.66 | +5.1% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $1.16 | $1.20 | +3.4% | ✓ BEAT |
Q1 2025 | Feb 6, 2025 | $1.28 | $1.52 | +18.8% | ✓ BEAT |
Q4 2024 | Oct 24, 2024 | $1.42 | $1.49 | +4.9% | ✓ BEAT |
Q3 2024 | Jul 25, 2024 | $1.36 | $1.37 | +0.7% | ✓ BEAT |
Q2 2024 | Apr 25, 2024 | $1.15 | $1.26 | +9.6% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $1.12 | $1.21 | +8.0% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $1.27 | $1.39 | +9.4% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $1.14 | $1.23 | +7.9% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.90 | $0.95 | +5.6% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $0.79 | $0.92 | +16.5% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.94 | $0.95 | +1.1% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.96 | $0.96 | 0.0% | = MET |
Q2 2022 | Apr 28, 2022 | $0.96 | $0.96 | 0.0% | = MET |
Q1 2022 | Feb 17, 2022 | $0.91 | $0.93 | +2.2% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.94 | $0.94 | 0.0% | = MET |
Q3 2021 | Jul 29, 2021 | $0.97 | $0.91 | -6.2% | ✗ MISS |
Latest News
Frequently Asked Questions about ATR
What is ATR's current stock price?
What is the analyst price target for ATR?
What sector is AptarGroup, Inc. in?
What is ATR's market cap?
Does ATR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ATR for comparison